EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach

Karla V Ow

Clinical Journal of Oncology Nursing · 15.07.2026

DOI: 10.1188/26.cjon.s2.e55-e66 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 15.07.2026. Verfasst von Karla V Ow. Beteiligte Einrichtung: Karla V. Ow. Hauptthemen laut MEDLINE: Oncology Nursing, Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with cancer undergoing advanced therapies, such as chimeric antigen receptor (CAR) T-cell therapy, experience complex treatment-related toxicities that require timely recognition and management. Nurses educate, monitor, and intervene to optimize outcomes and support quality survivorship care for patients. OBJECTIVES: This article highlights evidence-based interventions for managing treatment-related complications and outlines strategies to support safe, high-quality care throughout CAR T-cell treatment. METHODS: The author conducted a literature review using PubMed®, CINAHL®, and key oncology nursing guidelines to examine relevant studies, guidance, and expert consensus statements to synthesize best practices for nursing assessment and management of immune-based therapy complications. FINDINGS: Clinicians ensure safe and effective care through early toxicity recognition, standardized assessment protocols, and multidisciplinary coordination. Evidence-based interventions, as well as psychological support, contribute to improved patient outcomes. Ongoing education and professional development remain essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncology NursingNeoplasmsReceptors, Chimeric AntigenImmunotherapy, AdoptivePatient-Centered CareHumansFemaleMaleMiddle AgedAgedPractice Guidelines as TopicAdult

Stichwörter der Autor:innen

CAR T-cell therapyoncology nursingtreatment-related adverse events

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Karla V. Ow.

Zitieren

APA

Ow, K. V. (2026). Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.s2.e55-e66

Vancouver

Ow KV. Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.s2.e55-e66

BibTeX
@article{Ow2026,
  author = {Ow, Karla V},
  title = {Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach},
  journal = {Clinical Journal of Oncology Nursing},
  year = {2026},
  doi = {10.1188/26.cjon.s2.e55-e66}
}
Kostenlos starten →